Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Donor Cell Transplants ‘Chance of Cure’ in Rare Aggressive Lymphoma
August 2026
A new study of finds allogeneic stem cell transplants offer a genuine chance of cure in rare hepatosplenic T-cell lymphoma.
Read more
18 Aug 2026
Donor Cell Transplants ‘Chance of Cure’ in Rare Aggressive Lymphoma
A new study of finds allogeneic stem cell transplants offer a genuine chance of cure in rare hepatosplenic T-cell lymphoma.
17 Aug 2026
Omental Endothelial Cells Drive Ovarian Cancer Growth
New findings challenge the role of mature adipocytes in ovarian cancer growth and highlight omental endothelial FABP4 as a potential driver.
16 Aug 2026
MRI Sign May Help Distinguish Brain Radionecrosis from Metastases
An MRI sign showed potential for identifying brain radionecrosis after stereotactic radiotherapy, but its accuracy against recurrent metastases remains uncertain.
14 Aug 2026
Lung Cancer Treatment Duration Examined Across Japan
A national study found longer recorded lung cancer treatment duration at facilities with more specialists, but adjusted analyses showed no significant association.
12 Aug 2026
UK Lymphoma and Leukaemia Patients Access New Treatments
New NHS-approved therapies offer more treatment options for people living with lymphoma and leukaemia.
10 Aug 2026
Cancer Treatment Timing May Influence Survival and Toxicity
A systematic review of 35 studies suggested that cancer treatment timing, circadian rhythms, seasonality, latitude, and vitamin D status may influence systemic therapy outcomes, although prospective randomised trials are still needed.
9 Aug 2026
Social Prescribing Could Improve Radiation Therapy Care
Social prescribing could improve support for patients with cancer throughout non surgical oncology care and survivorship.
7 Aug 2026
Multi Omics Revealed New Gallbladder Cancer Targets
A review highlighted how integrated multi omics could improve diagnosis, biomarker discovery, treatment selection, and disease monitoring in gallbladder cancer, with future potential for AI and liquid biopsy.
Loading posts...
1
2
3
…
71
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View